Physician
Medical Group of Indiana LLC
Medical Group of Indiana LLC was paid $4.50M by Medicaid between Sep 2018 and Nov 2024, across 32 billing codes. Its largest line is J0717, Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 56% of everything it billed.
33Billing provider infoMEDICAL GROUP OF INDIANA LLC
MUNCIE, IN 47304
MUNCIE, IN 47304
33aNPI1306334255assigned 04/26/2018
33bProvider typeRheumatology Physician
28Total paid$4.50M
24GClaims40,461
24DCodes billed32
24AFirst – last monthSep 2018 – Nov 2024
Compared with peers
Next to other Rheumatology Physician providers in Indiana
Rank by total paid#1 of 13
Median peer was paid$124K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 484 | $4K | |
| 2019 | 3,403 | $156K | |
| 2020 | 3,490 | $845K | |
| 2021 | 5,185 | $736K | |
| 2022 | 6,044 | $902K | |
| 2023 | 16,564 | $1.61M | |
| 2024incomplete | 5,291 | $254K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 56% | 1,934 | 1,446 | $2.53M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 14,570 | 12,444 | $900K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9.9% | 453 | 307 | $447K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.8% | 3,339 | 2,891 | $304K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 3,303 | 2,818 | $126K |
| 96401 | 1.6% | 1,136 | 864 | $73K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,808 | 1,318 | $26K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | <1% | 20 | 14 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,987 | 1,569 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 445 | 395 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,528 | 1,224 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 385 | 283 | $5K |
20 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 1,174 | $4K |
| 86140 | <1% | 1,383 | $3K | |
| 85651 | <1% | 1,442 | $3K | |
| 80076 | <1% | 902 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 334 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 51 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 657 | $2K |
| 82607 | <1% | 319 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 337 | $2K |
| 82565 | <1% | 431 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 711 | $1K |
| 86160 | <1% | 122 | $1K | |
| 82550 | <1% | 311 | $834.06 | |
| 86430 | <1% | 314 | $817.99 | |
| 84550 | <1% | 246 | $474.06 | |
| 84460 | <1% | 155 | $306.69 | |
| 85027 | <1% | 83 | $294.66 | |
| 99423 | <1% | 18 | $216.31 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 526 | $163.31 |
| 84450 | <1% | 37 | $85.14 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKTELEH, TAREK (PRESIDENT)